TGFB1 and metabolic dysfunction-associated steatohepatitis: Overexpression of TGF-β in NAFLD or NASH activates the Smad signaling pathway, leading to apoptosis, hepatic stellate cells (HSCs) activation and proliferation, and myofibroblast (MFB) transformation, resulting in increased extracellular matrix (ECM) deposition (80).